A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System
Brian A. Swiglo,
M. H. Murad,
Holger J. Schünemann,
Regina Kunz,
Robert A. Vigersky,
Gordon H. Guyatt and
Victor M. Montori
Knowledge and Encounter Research Unit (B.A.S., M.H.M., V.M.M.), Divisions of Endocrinology, Preventive Medicine, and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905; Clinical Advances Through Research And Information Translation Research Group (H.J.S., G.H.G.), Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Ontario L8S4L8, Canada; Department of Epidemiology (H.J.S.), Italian National Cancer Institute "Regina Elena," 00161 Rome, Italy; Basel Institute for Clinical Epidemiology (R.K.), University Hospital Basel, CH-4031 Basel, Switzerland; and Diabetes Institute (R.A.V.), Walter Reed Health Care System, Washington, D.C. 20307
Address all correspondence and requests for reprints to: Victor M. Montori, M.D., M.Sc., Mayo Clinic, W18A, 200 First Street SW, Rochester, Minnesota 55905. E-mail: montori.victor{at}mayo.edu.
Context: The Endocrine Society, and a growing number of otherorganizations, have adopted the Grading of Recommendations,Assessment, Development, and Evaluation (GRADE) system to developclinical practice guidelines and grade the strength of recommendationsand the quality of the evidence. Despite the use of GRADE inseveral of The Endocrine Societys clinical practice guidelines,endocrinologists have not had access to a context-specific discussionof this system and its merits.
Evidence Acquisition: The authors are involved in the developmentof the GRADE standard and its application to The Endocrine Societyclinical practice guidelines. Examples were extracted from theseguidelines to illustrate how this grading system enhances thequality of practice guidelines.
Evidence Synthesis: We summarized and described the componentsof the GRADE system, and discussed the features of GRADE thathelp bring clarity and consistency to guideline documents, makingthem more helpful to practicing clinicians and their patientswith endocrine disorders.
Conclusions: GRADE describes the quality of the evidence usingfour levels: very low, low, moderate, and high quality. Recommendationscan be either strong ("we recommend") or weak ("we suggest"),and this strength reflects the confidence that guideline panelmembers have that patients who receive recommended care willbe better off. The separation of the quality of the evidencefrom the strength of the recommendation recognizes the rolethat values and preferences, as well as clinical and socialcircumstances, play in formulating practice recommendations.
This article has been cited by other articles:
R. E. Johnson and M. H. Murad Gynecomastia: Pathophysiology, Evaluation, and Management
Mayo Clin. Proc.,
November 1, 2009;
84(11):
1010 - 1015.
[Abstract][Full Text][PDF]
W. C. Hembree, P. Cohen-Kettenis, H. A. Delemarre-van de Waal, L. J. Gooren, W. J. Meyer III, N. P. Spack, V. Tangpricha, and V. M. Montori Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3132 - 3154.
[Abstract][Full Text][PDF]
A. Maiorana and S. Cianfarani Impact of Growth Hormone Therapy on Adult Height of Children Born Small for Gestational Age
Pediatrics,
September 1, 2009;
124(3):
e519 - e531.
[Abstract][Full Text][PDF]
P. E. Cryer, L. Axelrod, A. B. Grossman, S. R. Heller, V. M. Montori, E. R. Seaquist, and F. J. Service Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
March 1, 2009;
94(3):
709 - 728.
[Abstract][Full Text][PDF]
G. P. August, S. Caprio, I. Fennoy, M. Freemark, F. R. Kaufman, R. H. Lustig, J. H. Silverstein, P. W. Speiser, D. M. Styne, and V. M. Montori Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion
J. Clin. Endocrinol. Metab.,
December 1, 2008;
93(12):
4576 - 4599.
[Abstract][Full Text][PDF]
J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
October 1, 2008;
93(10):
3671 - 3689.
[Abstract][Full Text][PDF]
J. W. Funder, R. M. Carey, C. Fardella, C. E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., and V. M. Montori Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
September 1, 2008;
93(9):
3266 - 3281.
[Abstract][Full Text][PDF]
L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
May 1, 2008;
93(5):
1526 - 1540.
[Abstract][Full Text][PDF]
K. A. Martin, R. J. Chang, D. A. Ehrmann, L. Ibanez, R. A. Lobo, R. L. Rosenfield, J. Shapiro, V. M. Montori, and B. A. Swiglo Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1105 - 1120.
[Abstract][Full Text][PDF]